FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/04/2022
Back to search
Official data from USPTO
MALDI BIOTYPER SIRIUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MALDI BIOTYPER SIRIUS
ST13
US500000079258339Class
10
Filing
79258339
Registration
6495439
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
04/04/2022
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
03/13/2019
Registration date
09/28/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2021
Last transaction
09/28/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
HELMERS,SARA A
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Bruker Daltonics GmbH & Co. KG
Bruker Daltonik GmbH
Representatives
PAUL NOVAK HACKLER DAGHIGHIAN MARTINO & NOVAK
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Human and veterinary diagnostic instrumentsin particular mass spectrometers for use in medical and clinical applications for the identification or characterization of microorganismssuch as bacteriayeastsviruses and fungi
Publications
History of USPTO decisions and trademark events.
50 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/14/2022
FIMP
FINAL DISPOSITION PROCESSED
03/14/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/28/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
11/19/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
09/28/2021
GPNX
NOTIFICATION PROCESSED BY IB
07/18/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/13/2021
PUBO
PUBLISHED FOR OPPOSITION
07/13/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/23/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/23/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2021
EXPT
EXPARTE APPEAL TERMINATED
06/09/2021
EXAR
EXPARTE APPEAL AFFIRMED/REVERSED IN PART
03/26/2021
RBFT
REPLY BRIEF FILED - CHECK TTAB FILES
01/21/2021
GNSN
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
12/18/2020
GNES
EXAMINERS STATEMENT E-MAILED
12/18/2020
CNES
EXAMINERS STATEMENT - COMPLETED
12/18/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/09/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/01/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/30/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/21/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/14/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
10/14/2020
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
08/12/2020
GECD
ACTION DENYING REQ FOR RECON E-MAILED
08/12/2020
CNCF
ACTION CONTINUING FINAL - COMPLETED
08/12/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2020
ALIE
ASSIGNED TO LIE
08/03/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/20/2020
EXPI
EX PARTE APPEAL-INSTITUTED
07/20/2020
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
07/20/2020
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
07/20/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/18/2020
GNFR
FINAL REFUSAL E-MAILED
01/18/2020
CNFR
FINAL REFUSAL WRITTEN
01/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/20/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2019
RFNT
REFUSAL PROCESSED BY IB
07/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/21/2019
RFRR
REFUSAL PROCESSED BY MPU
06/21/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/31/2019
CNRT
NON-FINAL ACTION WRITTEN
05/30/2019
DOCK
ASSIGNED TO EXAMINER
05/22/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/14/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/10/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/09/2019
Continuous trademark protection
Get notified about every new filing that threatens MALDI BIOTYPER SIRIUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.